Cargando…

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

BACKGROUND: Rifaximin therapy reduced risk of hepatic encephalopathy (HE) recurrence and HE-related hospitalisations during a 6-month, randomised, placebo-controlled trial (RCT) and a 24-month open-label maintenance (OLM) study. However, the impact of crossover from placebo to rifaximin therapy is u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, J S, Barrett, A C, Bortey, E, Paterson, C, Forbes, W P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2015
Materias:	Rifaximin for Hepatic Encephalopathy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284039/ https://www.ncbi.nlm.nih.gov/pubmed/25339518 http://dx.doi.org/10.1111/apt.12993

Ejemplares similares

Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation
por: Alabsawy, Eman, et al.
Publicado: (2022)

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list
por: Salehi, Shayon, et al.
Publicado: (2019)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control
por: Yan, Bingyu, et al.
Publicado: (2023)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
por: Wang, Shao-Juan, et al.
Publicado: (2021)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
por: Lin, Kuan-Yin, et al.
Publicado: (2023)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

TEMPORAL TRENDS IN THE DETECTION RATES OF HEPATITIS B IN THE SANTA CATARINA STATE, BRAZIL
por: Marcon, Chaiana Esmeraldino Mendes, et al.
Publicado: (2014)

Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection
por: Jiang, Xinyi, et al.
Publicado: (2022)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
por: Li, Ning, et al.
Publicado: (2022)

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study
por: Tang, Zi-Min, et al.
Publicado: (2022)

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China
por: Zhou, Yi-Hua, et al.
Publicado: (2023)

Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019
por: Schemmerer, Mathias, et al.
Publicado: (2022)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL
por: de Souza, Eduardo Pernambuco, et al.
Publicado: (2014)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in Germany
por: Esber, Allahna L., et al.
Publicado: (2023)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Knowledge and awareness of viral hepatitis and influencing factors among the general population aged 15–69 years in Zhejiang Province, China
por: Zhou, Yang, et al.
Publicado: (2023)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
por: Wang, Xiaoli, et al.
Publicado: (2023)

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
por: Zhong, Guohua, et al.
Publicado: (2023)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023)

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways
por: Zhao, Zhenyu, et al.
Publicado: (2023)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022)

Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
por: Ridola, Lorenzo, et al.
Publicado: (2013)

Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt
por: Benova, Lenka, et al.
Publicado: (2015)

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
por: Kimer, Nina, et al.
Publicado: (2014)

Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy
por: Jesudian, Arun B., et al.
Publicado: (2020)

Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
por: Han, Xianghui, et al.
Publicado: (2021)

HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZON
por: Valois, Rubenilson Caldas, et al.
Publicado: (2014)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
por: Freitas, Solange Zacalusni, et al.
Publicado: (2014)

CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients
por: Tian, Yuan, et al.
Publicado: (2023)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_as7svlqgicphnoe6unfujqnsgv